• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Neoprobe lands J&J as partner

Article

Gamma probe developer Neoprobe has signed an agreement with Johnson & Johnson’s Ethicon Endo-Surgery division for sales and marketing of Neoprobe 1500, a portable radioisotope detector recently released by Neoprobe. Ethicon Endo-Surgery of

Gamma probe developer Neoprobe has signed an agreement with Johnson & Johnson’s Ethicon Endo-Surgery division for sales and marketing of Neoprobe 1500, a portable radioisotope detector recently released by Neoprobe. Ethicon Endo-Surgery of Cincinnati, OH, will have rights to promote Neoprobe 1500 and its reusable probes for one year in the U.S., and the two companies are in discussions over extending the deal to cover Europe, Japan, and Australia. Neoprobe of Dublin, OH, previously had an agreement with U.S. Surgical, but that deal broke down last year.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.